Health Canada has approved new brand names for Novo Nordisk's semaglutide products, marking a strategic regulatory move as the Danish pharmaceutical giant prepares for generic competition in the Canadian market
If for any reason, the physician does not approve, you will be instantly refunded.After purchase of this product, a physician will call you within 24 hour.
Still, clinical decisions depend on approval status, product labeling, side effects, diabetes treatment goals, cardiovascular risk, comorbid conditions, and patient preferences
Pancreatitis (inflammation of the pancreas) can occur in some users
Pharmacotherapy provides an adjunct or alternative, especially in cases where obesity is severe or complicated by metabolic conditions
Inform patients of the risk of hypoglycemia and educate them on the signs and symptoms